OH

Owen Hughes, Jr

CEO at Cullinan Therapeutics

United States, US

About

Owen Hughes, Jr is the CEO at Cullinan Oncology. Owen Hughes joined Intarcia in February 2013 as Chief Business Officer and Head of Corporate Development. Prior to Intarcia, Owen Hughes served as Director at Brookside Capital, an multi-billion dollar hedge fund that falls under the Bain Capital umbrella. There, he co-managed all public and private healthcare investments including biotechnology, med-tech, and services. Prior to his tenure at Brookside, Owen Hughes was Senior Portfolio Manager at Pyramis Global Advisors, a Fidelity Investments Company, a Co-founder and Partner at Triathlon Fund Management, an Investment Associate at Ziff Brothers Investments, an Assistant Vice President at Merrill Lynch/Morgan Stanley, where we provided sell-side coverage of specialty healthcare distributors, and a Financial Analyst in the healthcare group at PaineWebber. Owen Hughes received B.A. from Dartmouth College, where he received All-Ivy Honors, Academic All-Ivy Honors and was a four-year Le

Position in the VCSift Database

  • 3,360 investors hold the CEO role in VCSift. Owen Hughes, Jr is one of them.
  • 2,799 investors are based in United States.

Data sourced from 410,343 investor profiles. Updated July 2026.

Investment Focus

Location
US

Contact Information

em••••@example.com
linkedin.com/in/••••••••

Unlock contact details with a VCSift subscription

Unlock Contact

Already subscribed? Log in

Find more investors like Owen

Search Investors